Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anne Fung, MD
Perceive Biotherapeutics, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
11 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Sydney Retina Clinic and Day Surgery
Sydney, New South Wales, Australia
Active, not recruiting - Cerulea Clinical Trials
East Melbourne, Victoria, Australia
Active, not recruiting
- Rambam Medical Center
Haifa, Israel
Recruiting - Tel-Aviv Sourasky Medical Center, Ophthalmology Division
Tel Aviv, Israel
Recruiting
- Retina Macula Institute of Az
Scottsdale, Arizona, United States
Recruiting - the Retina Partners
Encino, California, United States
Recruiting - Retinal Consultants Medical Group
Sacramento, California, United States
Recruiting - Retina Consultants San Diego
San Diego, California, United States
Recruiting - Star Retina
Burleson, Texas, United States
Recruiting - Retina Center of Texas
Southlake, Texas, United States
Recruiting - University of Utah John A. Moran Eye Center
Salt Lake City, Utah, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Jun 2023
- Primary completion
- 30 Jun 2027
- Completion
- 31 Mar 2028
- Last update posted
- 15 Oct 2025
- Registered enrollment
- 60
- Registry id
- NCT06087458
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.